GNA Biosolutions
Series CGNA Biosolutions raised €12M in a Series C round in Jul 2019. The company is based in Munich, Germany. Investors in the round: GreyBird Ventures. Data as of Nov 2026.
Amount raised
€12M
€11,862,917
Native amount
13,500,000 USD
Stage
Series C
series c
Investors
1
Provenance & confidence
High confidenceAmount
13,500,000 USD
ECB-at-date → €12M · rate 1.138 on 2019-06-28
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Other rounds
same companyThis is the company's only recorded round.